IGF-1 DES · Performance
IGF-1 DES dosage by bodyweight
Reference dose ranges scaled across bodyweight bands, anchored to the most-cited research dose (30 mcg @ 75 kg). Educational only, never a recommendation.
| Bodyweight band | Reference dose range | At U-100 (1 mg/mL) | Vol. on U-100 (5 mg / 2 mL) | 5× t½ elapsed |
|---|---|---|---|---|
| <60 kg / <132 lb | 19–25 mcg | 0.02–0.03 mL | 1–1 units0.01–0.01 mL | – |
| 60–75 kg / 132–165 lb | 23–31 mcg | 0.02–0.03 mL | 1–1 units0.01–0.01 mL | – |
| 75–90 kg / 165–198 lb | 28–38 mcg | 0.03–0.04 mL | 1–2 units0.01–0.02 mL | – |
| 90–105 kg / 198–231 lb | 33–45 mcg | 0.03–0.04 mL | 1–2 units0.01–0.02 mL | – |
| >105 kg / >231 lb | 38–52 mcg | 0.04–0.05 mL | 2–2 units0.02–0.02 mL | – |
Volume column assumes a standard 5 mg vial reconstituted with 2 mL bacteriostatic water (concentration 2.5 mg/mL); insulin units shown for a U-100 syringe. No published half-life on file for IGF-1 DES; the elapsed-time column is hidden.
IGF-1 DES by goal
Read IGF-1 DES's profile and dosing through a specific research-goal lens.
Dose & PK references
Selected from the IGF-1 DES bibliography for relevance to dosing and pharmacokinetics.
- Superior potency of infused IGF-I analogues which bind poorly to IGF-binding proteins is maintained when administered by injection
- Insulin-like growth factor-I (IGF-I) analogue, LR(3)IGF-I, ameliorates the loss of body weight but not of skeletal muscle during food restriction
- Insulin-like growth factor-I (IGF-I) and especially IGF-I variants are anabolic in dexamethasone-treated rats
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.